Navigation Links
Custom and library siRNA for efficient gene silencing

bles a highly stringent hot start and allows reaction setup at room temperature without nonspecific artifacts. The newly developed multiplex PCR buffer in the master mix further enhances the sensitivity of the multiplex reaction. This innovative, new formulation was specifically developed and optimized for multiplex PCR. In contrast to conventional PCR reagents, the new buffer contains a balanced combination of salts and additives to ensure comparable efficiencies for annealing and extension of all primers in the reaction (Figure 1).

Successful 16plex PCR Using the QIAGEN Multiplex PCR Kit

Figure 1 Multiplex PCR of 16 targets (99C955 bp) was carried out for 35 cycles using standard conditions (Std) for the QIAGEN Multiplex PCR Kit (Q) without further optimization or using a variety of conditions with a hot-start DNA polymerase from Supplier AII (AII). A Comparison using 2.5 units/50 l reaction of the hot-start DNA polymerase from Supplier AII and with the indicated Mg2+ concentrations. B Comparison using the optimized Mg2+ concentration (3.5 mM) for the hot-start DNA polymerase from Supplier AII and the indicated amounts of enzyme per 50 l reaction. M: markers.

Versatile for many applications

The QIAGEN Multiplex PCR Kit is well suited for many types of multiplex PCR applications using different detection methods. PCR products can be visualized on agarose gels or detected using fluorescently labeled primers. Detection of fluorescently labeled products can be performed on automatic gel-based DNA sequencers (e.g., the ABI PRISM 377 DNA Sequencer; Figure 2), as well as those based on capillary electrophoresis (e.g., the ABI PRISM 310 Genetic Analyzer).
'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Custom and library siRNA for efficient gene silencing
2. Custom siRNA Oligo Synthesis Service
3. Ambion Custom
4. Ambion Custom: Made-to-Order
5. Custom RNA & RNA Isolation Services to Meet Your Specific Needs
6. Cancer siRNA Oligo Set Version 1.0
7. Library siRNA
8. Efficient RNAi-mediated gene silencing in neuronal cells using QIAGEN siRNA and TransMessenger Transfection Reagent*
9. Quantification of siRNA Silencing Efficiency Using the LightCycler System
10. Housekeeping Genes: Universal Positive Controls in siRNA Knockdown Experiments
11. Confirming gene silencing mechanism by pGFP/GFP22 siRNA co-transfection

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Custom and library siRNA for efficient gene silencing

(Date:11/8/2009)...9 Complete Genomics, a third-generation human gen...n of a report in the journal Science describing ... analysis of sequence data from three complete hum...enomes sequenced on the proof-of-principle genomic...e to $1,726 for 45x coverage for the samples descr...
(Date:11/6/2009)... Myriant Technologies LLC ("Myriant"), a privately...wable bio-chemicals, Uhde Corporation of America a...e of the world,s leading engineering contractors (...ineering, procurement & construction (EPC) of ...enewable feedstocks. The execution of this allian...
(Date:11/6/2009)...-- Intarcia Therapeutics, Inc. delivered two prese...uous delivery of exenatide) program for the treatm...s Technology Meeting in San Francisco, CA: ,, (...1/SFTU126LOGO ) ,, Continuous Subcutaneous De...cose, HbA1c and Reduces Weight in a 28-day Phase 1...
(Date:11/5/2009)... -- DSM Pharmaceutical Products today announced th...ix, Saint Jean D,Illac, France, where DSM will be ...er for Galenix commercial products on a global bas...ness development opportunities co-marketing Galeni...h of Galenix in drug product development and clini...
Breaking Biology Technology:Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...d, CAESAREA, Israel, March 26 Alma Lasers Ltd., ...nd radiofrequency systems,announces important deve...hich is being litigated in the United States Distr...e U.S. Patent and Trademark Office in,Alexandria V...menis,s,patents that are at issue in the litigatio...
...pril 1, 2008, LEVERKUSEN, Germany, and PITTSBURGH...ate MEDRAD, Inc. announced,today that it has succe...ding shares of common stock of Possis Medical, Inc...as advised MEDRAD that, as of the expiration,of th...ay, March 25, 2008,a total of 14,951,550 Possis Me...
...h CyberKnife System to Date, SUNNYVALE, Calif., M...global leader in the field of radiosurgery,announc...fe centers,worldwide are now treating lung cancer ...*. The number of lung cancer patients is growing,s...uals receiving,CyberKnife treatments to date., Lu...
Other Biology Technology:U.S. PTO Reexamining Lumenis Patents 2Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period 2Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period 3CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 2CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 3CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 4
(Date:11/4/2009)..., 2009 Childhood obesity in the United States is ...fourth of advertising on daytime and prime time te...uing questions about the role television plays in ... the Journal of Nutrition Education and Behavior ...ight be a large contributor to the problem. , Re...
(Date:11/4/2009)...., Oct. 19 Spectros, developer and...aging devices which shed light on life-threatening...usive distribution deals for both its T-Stat®...ered include Australia, New Zealand, The Netherla...y, France, Spain, Portugal, Poland, Greece, Turkey...
(Date:11/4/2009)... What,s the cost of saving a teenag...th resulting from prescription medication abuse, t... however, may be unaware that the lock-boxes they,...he ticking timebomb of prescription drugs. That,s ...ty medical supplies, has formed an exclusive partn...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Spectros Signs New International Distribution Deals 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3New biomarker method could increase the number of diagnostic tests for cancer 9054 1New biomarker method could increase the number of diagnostic tests for cancer 9054 2New biomarker method could increase the number of diagnostic tests for cancer 9054 3New biomarker method could increase the number of diagnostic tests for cancer 9054 4LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 1LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 2LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 3LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 4Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program 50315 1Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program 50315 2Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program 50315 3
...transplant patients reject their new organs requir...accept or reject each other. Xavier Fernndez-Busqu...y of Barcelona, has found the perfect ally in this...ies that grows abundantly from just north of Cape ...icrociona prolifera) has a cell-to-cell recognitio...
... water is a scene with which we,re all familiar. Y...rable amount of time in the water–polar bears, sea...a thick layer of body fat to keep warm. They rely,...ir fur and the densely packed layer of specially a...scopy and polarizing light microsopy, John W. Weis...
... water is a scene with which we,re all familiar. Y...rable amount of time in the water–polar bears, sea...a thick layer of body fat to keep warm. They rely,...ir fur and the densely packed layer of specially a...scopy and polarizing light microsopy, John W. Weis...
Other Biology News:Simple sea sponge helps scientists understand tissue rejection 2Genome Sequence for Haemophilus Influenzae Completed 2Genome Sequence for Haemophilus Influenzae Completed 3Otter adaptations: How do otters remain sleek and warm 2Otter adaptations: How do otters remain sleek and warm 3
Goat Anti-ZBP-89 (S-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Enolase from baker's yeast (S. cerevisiae) from Sigma-Aldrich
UNOsphere S Support, 100 ml from Bio-Rad
Baker's yeast (S. cerevisiae) Phosphoglucose isomerase from Sigma-Aldrich
Biology Products: